Detailed information for compound 836857

Basic information

Technical information
  • TDR Targets ID: 836857
  • Name: 2-[4-(4-tert-butylphenyl)-2,2-dimethyl-5-oxoi midazol-1-yl]-N-(3,4-difluorophenyl)acetamide
  • MW: 413.46 | Formula: C23H25F2N3O2
  • H donors: 1 H acceptors: 2 LogP: 4.41 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(CN1C(=O)C(=NC1(C)C)c1ccc(cc1)C(C)(C)C)Nc1ccc(c(c1)F)F
  • InChi: 1S/C23H25F2N3O2/c1-22(2,3)15-8-6-14(7-9-15)20-21(30)28(23(4,5)27-20)13-19(29)26-16-10-11-17(24)18(25)12-16/h6-12H,13H2,1-5H3,(H,26,29)
  • InChiKey: XSUFQRMYWRJWOR-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 2-[4-(4-tert-butylphenyl)-2,2-dimethyl-5-oxo-imidazol-1-yl]-N-(3,4-difluorophenyl)acetamide
  • 2-[4-(4-tert-butylphenyl)-2,2-dimethyl-5-oxo-1-imidazolyl]-N-(3,4-difluorophenyl)acetamide
  • 2-[4-(4-tert-butylphenyl)-5-keto-2,2-dimethyl-imidazol-1-yl]-N-(3,4-difluorophenyl)acetamide
  • 2-[4-(4-tert-butylphenyl)-2,2-dimethyl-5-oxo-imidazol-1-yl]-N-(3,4-difluorophenyl)ethanamide
  • C924-0641
  • NCGC00114438-01

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Equus caballus Ferritin light chain Starlite/ChEMBL No references
Homo sapiens tumor protein p53 Starlite/ChEMBL No references
Homo sapiens glucagon-like peptide 1 receptor Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus multilocularis tumor protein p63 Get druggable targets OG5_140038 All targets in OG5_140038
Echinococcus granulosus tumor protein p63 Get druggable targets OG5_140038 All targets in OG5_140038

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Loa Loa (eye worm) pigment dispersing factor receptor c glucagon-like peptide 1 receptor 463 aa 388 aa 25.8 %
Schistosoma mansoni ferritin Ferritin light chain   175 aa 171 aa 43.9 %
Schistosoma mansoni ferritin Ferritin light chain   175 aa 171 aa 44.4 %
Echinococcus granulosus expressed protein Ferritin light chain   175 aa 146 aa 28.8 %
Schistosoma japonicum Ferritin, putative Ferritin light chain   175 aa 144 aa 24.3 %
Schistosoma mansoni apoferritin-2 Ferritin light chain   175 aa 142 aa 29.6 %
Echinococcus multilocularis expressed protein Ferritin light chain   175 aa 146 aa 30.1 %
Schistosoma mansoni apoferritin-2 Ferritin light chain   175 aa 146 aa 28.8 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Brugia malayi Fatty acid desaturase family protein 0.0032 0.0559 0.1345
Leishmania major delta-6 fatty acid desaturase 0.0032 0.0559 0.1415
Wolbachia endosymbiont of Brugia malayi bacterioferritin/cytochrome b1 0.001 0 0.5
Echinococcus multilocularis Peptidase M, neutral zinc metallopeptidases, zinc binding site 0.0032 0.0559 0.0559
Brugia malayi latrophilin 2 splice variant baaae 0.0041 0.0777 0.1922
Echinococcus multilocularis Peptidase M, neutral zinc metallopeptidases, zinc binding site 0.0032 0.0559 0.0559
Mycobacterium leprae PROBABLE BACTERIOFERRITIN BFRA 0.001 0 0.5
Loa Loa (eye worm) CAMK/CAMKL/CHK1 protein kinase 0.0163 0.3835 1
Echinococcus multilocularis cadherin EGF LAG seven pass G type receptor 0.0019 0.0221 0.0221
Echinococcus granulosus Fatty acid desaturase type 1 0.0032 0.0559 0.0559
Trypanosoma cruzi fatty acid desaturase, putative 0.0155 0.3648 1
Leishmania major fatty acid desaturase, putative,sphingolipid delta 4 desaturase, putative 0.0032 0.0559 0.1415
Mycobacterium ulcerans linoleoyl-CoA desaturase, DesA3 0.0032 0.0559 1
Treponema pallidum bacterioferrin (TpF1) 0.001 0 0.5
Mycobacterium ulcerans electron transfer protein FdxB 0.0032 0.0559 1
Leishmania major delta-5 fatty acid desaturase 0.0032 0.0559 0.1415
Trypanosoma brucei fatty acid desaturase, putative 0.0155 0.3648 1
Brugia malayi acyl-CoA desaturase 0.0123 0.2832 0.735
Trypanosoma cruzi delta-4 fatty acid desaturase, putative 0.0032 0.0559 0.1415
Plasmodium vivax stearoyl-CoA desaturase (acyl-CoA desaturase, faty acid desaturase), putative 0.0123 0.2832 0.5
Mycobacterium ulcerans linoleoyl-CoA desaturase, DesA3_2 0.0032 0.0559 1
Schistosoma mansoni serine/threonine protein kinase 0.0163 0.3835 1
Onchocerca volvulus 0.0155 0.3648 1
Leishmania major fatty acid desaturase, putative 0.0032 0.0559 0.1415
Brugia malayi Protein kinase domain containing protein 0.0163 0.3835 1
Trypanosoma brucei cytochrome b5-dependent oleate desaturase 0.0032 0.0559 0.1415
Schistosoma mansoni hypothetical protein 0.0019 0.0221 0.0578
Echinococcus multilocularis diuretic hormone 44 receptor GPRdih2 0.0019 0.0221 0.0221
Mycobacterium tuberculosis Probable conserved membrane protein 0.0032 0.0559 1
Trypanosoma cruzi fatty acid desaturase, putative 0.0032 0.0559 0.1415
Leishmania major delta-4 fatty acid desaturase 0.0032 0.0559 0.1415
Schistosoma mansoni hypothetical protein 0.0019 0.0221 0.0578
Loa Loa (eye worm) hypothetical protein 0.006 0.1256 0.3187
Trypanosoma cruzi fatty acid desaturase, putative 0.0032 0.0559 0.1415
Leishmania major stearic acid desaturase, putative 0.0155 0.3648 1
Loa Loa (eye worm) hypothetical protein 0.0041 0.0777 0.1922
Trypanosoma cruzi cytochrome b5-dependent oleate desaturase 0.0032 0.0559 0.1415
Trypanosoma brucei delta-4 fatty acid desaturase 0.0032 0.0559 0.1415
Onchocerca volvulus 0.0155 0.3648 1
Loa Loa (eye worm) pigment dispersing factor receptor c 0.006 0.1256 0.3187
Brugia malayi Latrophilin receptor protein 2 0.0019 0.0221 0.0454
Loa Loa (eye worm) hypothetical protein 0.006 0.1244 0.3155
Brugia malayi calcium-independent alpha-latrotoxin receptor 2, putative 0.0019 0.0221 0.0454
Mycobacterium ulcerans hypothetical protein 0.0032 0.0559 1
Loa Loa (eye worm) latrophilin receptor protein 2 0.0019 0.0221 0.0454
Trypanosoma cruzi delta-4 fatty acid desaturase, putative 0.0032 0.0559 0.1415
Leishmania major fatty acid desaturase, putative,sphingolipid delta 4 desaturase, putative 0.0032 0.0559 0.1415
Echinococcus multilocularis tumor protein p63 0.0408 1 1
Mycobacterium ulcerans hypothetical protein 0.0032 0.0559 1
Leishmania major fatty acid desaturase, putative,sphingolipid delta 4 desaturase, putative 0.0032 0.0559 0.1415
Schistosoma mansoni fatty acid desaturase 0.0032 0.0559 0.1457
Mycobacterium ulcerans cytochrome P450 185A4 Cyp185A4 0.0012 0.005 0.0891
Loa Loa (eye worm) fatty acid desaturase 0.0032 0.0559 0.1345
Schistosoma mansoni cellular tumor antigen P53 0.006 0.1244 0.3244
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.006 0.1256 0.3187
Loa Loa (eye worm) fatty acid desaturase 0.0032 0.0559 0.1345
Mycobacterium tuberculosis Possible electron transfer protein FdxB 0.0032 0.0559 1
Schistosoma mansoni hypothetical protein 0.0019 0.0221 0.0578
Leishmania major delta-12 fatty acid desaturase 0.0032 0.0559 0.1415
Onchocerca volvulus 0.006 0.1244 0.2218
Trypanosoma cruzi fatty acid desaturase, putative 0.0123 0.2832 0.7732
Echinococcus multilocularis Fatty acid desaturase, type 1 0.0032 0.0559 0.0559
Trypanosoma cruzi sphingolipid delta 4 desaturase, putative 0.0032 0.0559 0.1415
Brugia malayi Calcitonin receptor-like protein seb-1 0.006 0.1256 0.3187
Trypanosoma brucei sphingolipid delta 4 desaturase, putative 0.0032 0.0559 0.1415
Toxoplasma gondii sphingolipid delta 4 desaturase/c-4 hydroxylase protein des2 family protein 0.0032 0.0559 0.5
Trypanosoma cruzi fatty acid desaturase, putative 0.0123 0.2832 0.7732
Trypanosoma brucei delta-6 fatty acid desaturase, putative 0.0032 0.0559 0.1415
Brugia malayi Delta5 fatty acid desaturase 0.0032 0.0559 0.1345
Loa Loa (eye worm) hypothetical protein 0.0032 0.0559 0.1345
Leishmania major fatty acid desaturase, putative,sphingolipid delta 4 desaturase, putative 0.0032 0.0559 0.1415
Echinococcus granulosus diuretic hormone 44 receptor GPRdih2 0.0019 0.0221 0.0221
Leishmania major fatty-acid desaturase, putative 0.0155 0.3648 1
Loa Loa (eye worm) hypothetical protein 0.0019 0.0221 0.0454
Loa Loa (eye worm) acyl-CoA desaturase 0.0123 0.2832 0.735
Trichomonas vaginalis ferritin, putative 0.001 0 0.5
Leishmania major fatty acid desaturase, putative 0.0032 0.0559 0.1415
Loa Loa (eye worm) FAT-3 protein 0.0032 0.0559 0.1345
Brugia malayi Fatty acid desaturase family protein 0.0032 0.0559 0.1345
Echinococcus granulosus Sphingolipid delta4 desaturase DES1 0.0032 0.0559 0.0559
Echinococcus granulosus cadherin EGF LAG seven pass G type receptor 0.0019 0.0221 0.0221
Schistosoma mansoni hypothetical protein 0.0041 0.0777 0.2027
Plasmodium falciparum stearoyl-CoA desaturase 0.0123 0.2832 0.5
Mycobacterium ulcerans linoleoyl-CoA desaturase, DesA3 0.0032 0.0559 1
Schistosoma mansoni hypothetical protein 0.0019 0.0221 0.0578
Mycobacterium tuberculosis Probable transmembrane alkane 1-monooxygenase AlkB (alkane 1-hydroxylase) (lauric acid omega-hydroxylase) (omega-hydroxylase) (f 0.0032 0.0559 1
Echinococcus multilocularis GPCR, family 2 0.0019 0.0221 0.0221
Mycobacterium ulcerans transmembrane alkane 1-monooxygenase AlkB 0.0032 0.0559 1
Echinococcus granulosus GPCR family 2 0.0019 0.0221 0.0221

Activities

Activity type Activity value Assay description Source Reference
Potency (binding) = 10 um PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] ChEMBL. No reference
Potency (functional) 11.2202 uM PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 12.5893 um PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 15.8489 um PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 22.3872 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] ChEMBL. No reference
Potency (functional) = 31.6228 um PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ] ChEMBL. No reference
Potency (functional) 89.1251 uM PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 100 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.